Viewing SEC Facts Units
Company Name:
PhaseBio Pharmaceuticals, Inc.
CIK:
1169245
Start Filing Date:
2022-01-01
End Filing Date:
2022-03-31
ACCN:
0001169245-22-000049
Value:
$ 48,635,034
Value Error:
$ None
Created By:
Date Filed:
2022-05-16
FY:
2022
Fiscal Period:
Q1
Frame:
CY2022Q1
Type:
us-gaap
Form:
10-Q
Units:
shares